Chemical Component Summary

Name5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid
Identifiers5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid
FormulaC19 H12 Cl N3 O2
Molecular Weight349.77
TypeNON-POLYMER
Isomeric SMILESc1cc(cc(c1)Cl)Nc2c3ccncc3c4ccc(cc4n2)C(=O)O
InChIInChI=1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25)
InChIKeyMUOKSQABCJCOPU-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count37
Chiral Atom Count0
Bond Count40
Aromatic Bond Count22

Drug Info: DrugBank

DrugBank IDDB15408 
NameSilmitasertib
Groupsinvestigational
DescriptionSilmitasertib is under investigation in clinical trial NCT03904862 (Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery).
SynonymsSilmitasertib
Categories
  • Casein Kinase II, antagonists & inhibitors
  • Heterocyclic Compounds, Fused-Ring
CAS number1009820-21-6

Related Resource References

Resource NameReference
PubChem24748573
ChEMBLCHEMBL1230165
PharosCHEMBL1230165